Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the update from Josh
Just a guess, but maybe Mr. Torenson wants to enter the hemp industry on his own in another capacity and not have a conflict of interest. He stated that he would continue with the company on consulting projects as needed so he doesn't appear to be breaking ties all together.
Here is my summary of the situation at this time.
I believe the Board members own the right to the warrants that are coming up to be exercised. I tried to look back in past filings but couldn't find it so maybe some of our other stock posters here can find it.
So my belief is by the recent filings is the insiders have been selling the stock at the current levels to buy back the warrants/stock options that need to be exercised soon. They sell the stock at this higher price level and then turn around buying the warrants/stock options at the lower levels in the warrant/stock option price and pocket the difference. Then they don't have to shell out the cash of their own pockets to make the purchases.
They are definitely buyers around due the daily volume but why would you drive it up before the warrant/stock option date takes effect? It would make sense to do that if you were a buyer this way you can buy more shares cheaper and keep it around the current price level.
This is just my opinion. I believe this stock is a homerun and while frustrating, it will pay off in a huge way in the not to distant future.
Good luck to all.
Totally understand your frustration but patience is needed. The hemp section is obviously the newest and biggest sector and constantly gets new companies entering the business everyday.
Researching the bios of the management staff, it appears that the company has some talented people in place to move in a positive direction. I like that the company has the Cash Merchant Division to make it diversified in case the hemp division struggles for a while to get the Holy Cacao product out.
The other aspect I like is the low share float. Any reasonable size deals or uptick in revenue stream should really push the shares higher quickly. The proof will be in the annual filing which I believe is due out by the end of this month.
Best of luck and patience to all.
If the company paid for an advertisement or a press release which I seriously doubt they did, then I would worry. But if it was just mentioned by a flipper (which all p&d traders do and the purpose of those chat boards), then nothing to be concerned of. By the end of 2019, this company will be at the top of gold standards for any cannabis/marijuana stock. Best of luck to all.
Just speculation on my part, but maybe Mr. Sandberg has decided to leave the company with the annual shareholder meeting coming up soon. I have no knowledge but I think he and Mr. Roper were close and with Mr. Roper's passing, he decided to move on. He received the 25,000 shares when he took on the role of CEO.
Maybe the wording of the stock compensation states you must sell your shares if you decide to leave the company.....just guessing on my part.
Just surprising when all the news looks so good for the future. Meanwhile with the weakness in the market yesterday, the stock held like a rock after our recent run up the past few days.
Wishing all the best to everyone.
$12-$15 target currently
Based on this latest deal and the revenue projections from it, I would say that a $12-$15 price target is realistic soon. If some additional deals get announced near term, then we could see the $20-$25 range especially if revenue projections are in the $100 million range totaling all the acquisitions.
Just my opinion. Good luck to all. 2019 is looking good.
It has been a longer than expected wait but everything is falling into place. This company has a grand slam written all over it. Just a matter of time. The only sad thing is that Brett Roper isn't around to see all his hard work paying off. May he rest in peace and smile from above as we will get to a big cash payout in the future.
2019 is going to be our year. Good luck to all!
Knife,
Yes, someone is taking tax losses IMO especially since we are near the 52 week low. If this company isn't a homerun in the cannabis sector, then none will be since MDCL is one of the very few stocks that actually makes a profit.
Good luck to all and best wishes for a great 2019.
Hoop
Yes, it is a frustrating time, but the company has kept up on their financials (which if they hadn't, we could be in trouble) and many shareholders are taking losses to offset their profits in other stocks before the end of the year.
In my opinion, I don't like companies that post press releases just to stay in the limelight (especially if there is nothing substantial behind it) to try to keep the stock price artificially higher. With this very low float, any real positive news will bump this much higher and quickly.
Owning this stock is a risk, but I like the personnel they have on board to get it in the right direction and they appear to be managing their finances well during this time.
I think we have a winner here, but it won't be for another 3-6 months in my opinion. Good luck to all.
Definitely a frustrating time but with the weakness in the market we are holding well. There is buy interest at this level which is helping. As more states legalize cannabis and possibly the federal government sometime after the new year, MDCL should be in good shape. The main thing is the low float and the company being profitable will bode well for the future. Hang in there, GLTA.
Super Earnings!
Great earnings report. The only reason we haven't gotten a major run to the upside is because the company never released the earnings report on the major newswires so it didn't bring in more interest. We had great volume on Friday due to the people that follow the stock or the sector. It was a great opportunity to accumulate at these prices due to the downside stock market on Friday.
If the company releases the earnings report next week on the major newswires it should bring additional interest from new investors. MDCL is one of the best cannabis operators in the industry and it is just a matter of time before this stock sees double digits. Good luck to all.
Jeff Sessions out, could be a positive sign?
With the resignation of Jeff Sessions, the cannabis sector could see some relief and stage a rally. When Sessions was named to the post of AG, the cannabis stocks began their gradual decline. Sessions was a strong opponent to any marijuana or cannabis industry becoming legal. With the election over and Sessions gone, the opposition by the federal government can have a chance to take a back seat and maybe move forward in a positive way. IMHO. Good luck to all MDCL holders.
Just need patience, many of the cannabis stocks are in a holding and consolidation pattern right now. When MDCL next earnings come out, that should be our real driver to price appreciation....IMO.
Just amazing how a company that is one of the best in the cannabis business isn't seeing its stock price moving upwards. This company is run by educated people that are doing all the right things involving growth and revenue streams. They don't issue BS press releases and give honest reviews of their company vs competitors in the same business.
Whoever is selling this stock in this volume will be regretting their dilution. Stock price should always be based on shares outstanding, earnings, growth potential. Since all of these traits are on the positive side, this stock should see $5.00 soon and $20.00 within a year and will be viewed as one of the leaders in the industry.
Patience is a virtue and that will be rewarded. Just my thoughts and good luck to all.
Nice earnings report. The turnaround has begun. We are in profit territory.
So let me understand that you are basing your assumptions on something from 4 years ago? The company continues to get new clients and expand sales and that is because they sell lousy cannabis? Maybe you should go back to Denver and check again.
The stock is doing lousy because of a blind trust selling shares, computer algorithms and share holders with weak stomachs. Just a educated guess but many times blind trust sell shares are predetermined intervals to liquify their assets and get a reasonable average price over the course of their holdings. Only the trust administrator knows why it is selling.
The company wouldn't come out with a press release about future earnings unless they were confident that were going to meet that projection or they could get in real trouble. If the blind trust is done selling shares and the stock chart reverses into positive territory, we could get a substantial run to new highs with computer algorithms being a major push and the future earnings report.
You can have your opinion to believe and state whatever you want about the company and I would respect it more if it were something more recent about your fact finding. So we will disagree on the future of this company. The opportunity to get a big profit or loss especially with the low float is worth the risk in my opinion. Best of luck to all.
This stock will be $20-$25 by the end of the year. With the low float and profitability along with being one of the leaders in the business, this hidden gem will be the trend setter in this field. MDCL doesn't issue stock to pay their bills which is a big plus unlike all the penny stocks that do.
If the Federal Government eases it's crackdown on Cannabis/marijuana, then the high price range could be $50 plus.
The hardest part is being patient. But hang in there, we will be rewarded.
Nice try, but MDCL has only 21 million shares outstanding and no debt. POTN has 269 million shares outstanding and almost 2 million debt on it's books.
If our government continues easing it's stance to abide by the state's legalization on cannabis and keeping Session's out of the picture, then MDCL is at least a $20-$25 stock, while POTN won't get above $1 because it has too much float.
And who knows, maybe with Trump being the businessman he is will realize to put pressure on making cannabis legal so the government can start getting tax revenue from it. If that were to be lucky enough to happen, then who knows how high these stocks could go.
Good luck with your investment in POTN, but I keep on planning that MDCL will be winning the race.
Pono Publications & Success Nutrients Deal Completed
Medicine Man Technologies Agrees to Acquire Pono Publications and Success Nutrients
Mar 03, 2017
OTC Disclosure & News Service
-
Denver, Colorado, March 03, 2017 (GLOBE NEWSWIRE) -- Medicine Man Technologies Inc. (OTCQB: MDCL), one of the country’s leading cannabis branding and consulting companies, announced today that it has entered into agreements to acquire both Pono Publications Ltd. and Success Nutrients, Inc., each a privately held Colorado corporation. Medicine Man has agreed to issue 7 million shares of its common stock as consideration for the acquisition, which represents approximately 40% interest in the Company.
As a part of this new acquisition, the Company has retained of Mr. Josh Haupt as its Chief Cultivation Officer, noting Mr. Haupt will serve as a key member of management, reporting to the Board of Directors which will now include Mr. Charley Haupt, Josh’s father a well-respected professional in the national energy management sector.
The Pono Publications Ltd brand includes the Three A Light™ cultivation book, along with the recently released professional-grade version developed in collaboration with MMT exclusively for both Three A Light™ and Medicine Man Technologies clients. This exceptional cultivation methodology is achieving significant results delivering annualized yields of cured cannabis of approximately 700-grams per square foot of flower canopy and is deployable in both greenhouse and indoor based cultivation facilities.
The Success Nutrients and Pono brands provide the key underpinnings of an enhanced cultivation methodology and is essential to the overall Three A Light™ performance metric. With an investment of two years of research, development and intense testing, this product line was specifically formulated for the cannabis industry and is producing significant results for its users throughout North America.
The synergy of these companies is expected to accelerate growth of all of the Company’s product and service lines, including the potential for increased revenues. As an example, the Company anticipates generating additional revenues from its recently announced new product line, Cultivation MAX. At the signing of a client’s new Cultivation MAX facility in Clark County Nevada this week, Mr. Josh Haupt stated, “This client’s five hundred plus light facility and planned expansions should enable us to generate a high six figure annual income starting later this summer, as we complete the integration of the Three A Light Professional Grade and Success Nutrient regimens.” However, there can be no assurances that these additional revenues will be generated.
Regarding the acquisition, Andy Williams, MMT’s CEO and co-founder noted, “We could not be more excited to welcome Pono Publications and Success Nutrients to the Medicine Man Technologies family. I believe Josh Haupt and Three A Light™ are the best industrial cultivators of cannabis in the world and are unmatched in their ability to produce quality, high-yielding crops. The complimentary nature of Pono and Success Nutrients to our existing practice has already created a new line of business and we believe will allow exponential growth on all fronts, establishing Medicine Man Technologies as the gold standard of cannabis cultivation.
Josh Haupt, principal and founder of Pono Publications and Success Nutrients stated, “After spending many years in development of both my proprietary nutrient line and cultivation methodologies, I am pleased to have found a new partnership opportunity that we believe will be mutually beneficial. The fact that Medicine Man Technologies is also a well-known presence in the cannabis industry should allow us to add substantial value back to the business as a whole while making more efficient use of our mutual resources.”
While no guarantees can be offered, the Company expects significant revenue growth with the addition with these two innovative business noting that during the first two months of operations in FY 2017, Pono Publications (Three A Light™) and Success Nutrients generated strong profitability on revenues in excess of $270,000, a trend the Company expects to continue under Mr. Haupt’s continued oversight.
About Medicine Man Technologies, Inc.
Established in March 2014, the Company secured its first client/licensee in April 2014. To date, they have provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. It currently has twenty eight active clients in 12 states and Puerto Rico, focusing on working with clients to 1) utilize its experience, technology, and training to help secure a license in states with newly emerging regulations, 2) deploy the Company's highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, 4) stay engaged with an ever expanding team of licensees and partners, all focused on quality and safety that will 'share' the ever-improving experience and knowledge of the network, and 5) continuing the expansion of its Brands Warehouse concept.
Safe Harbor Statement
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the Securities and Exchange Commission. Among other matters, the Medicine Man Technologies may not be able to sustain growth or achieve profitability based upon many factors including, but not limited to, general stock market conditions. Reference is hereby made to cautionary statements set forth in the company’s most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing and new service lines, noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations where we will be providing services, the impact of which cannot be predicted at this time.
Contact Information:
Attention Brett Roper via info@medicinemantechnologies.com
Telephone (303) 371-0387
Copyright © 2017 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Morningstar Disclaimer
Thoughts about news postings:
Just wanted to add a few thoughts, I have read quite a few comments about the company not making press releases to promote the company. Many companies do constant press releases with the same news over and over, just rewording them. That is a big sign that there is nothing there and just a way to fluff up their stock price, then later on have the stock price fall to pennies when the reality sets in of their business model and P&L shows the company bleeding.
I believe the MDCL management team is doing the right thing to keep things rolling along without much fanfare until necessary when advancements in the company will send the stock price upward. Just something to keep in mind, the low stock float can make price swings exaggerated and this company is one of the leaders in the industry and profitable.
Thanks for all the feedback, glad to see you all here lurking in the shadows.
Hooparena
So where did everyone go? Has everyone lost hope? I think the North Star Asset Management purchase shows promise, the only thing that is needed is patience. Thoughts, anyone?